News in brief | Nature Reviews Drug Discovery
Why AstraZeneca and others racing to make a COVID-19 vaccine should be more open about the process
Scientists relieved as coronavirus vaccine trial restarts — but question lack of transparency
EUR068: Enforcement (No. 2006/857/EC, Case COMP/A.37.507/F3 — AstraZeneca), Decision, 2005
AstraZeneca accelerates drug discovery thanks to PELE technology | BSC-CNS
PDF) Lessons learned from the fate of AstraZeneca's drug pipeline: A five-dimensional framework
AstraZeneca deal to supply EU with 300 million COVID-19 vaccine doses - CGTN
A leading coronavirus vaccine trial is on hold: scientists react
APO Group - Africa Newsroom / Press release | AstraZeneca to partner with UNICEF to help prevent non-communicable diseases among five million young people worldwide
AstraZeneca aims to go carbon free by 2025—and it'll spend $1B to do it | FiercePharma
Daily briefing: 'Serendipity' boosted Oxford–AstraZeneca vaccine's efficacy
Halting the Oxford vaccine trial doesn't mean it's not safe – it shows they're following the right process
AstraZeneca's COVID-19 Vaccine Trial Is On Hold Because A Volunteer Became Ill : Coronavirus Updates : NPR
AstraZeneca COVID-19 vaccine shows average efficiency of 70% - CGTN
COVID-19 clinical MDT experience sharing webcast
Oxford and AstraZeneca to resume Covid vaccine trial, Health News, ET HealthWorld
AstraZeneca Faces Difficult Questions About Its Vaccine After Admitting Mistake - The New York Times
PDF) Lessons learned from the fate of AstraZeneca's drug pipeline: A five-dimensional framework
COVID-19: Difficult trade-offs in AstraZeneca vaccine development | Science| In-depth reporting on science and technology | DW | 28.10.2020
Impact of a five-dimensional framework on R&D productivity at AstraZeneca | Nature Reviews Drug Discovery
Egypt - AstraZeneca
AstraZeneca's COVID-19 vaccine shows midphase promise in seniors | FierceBiotech
AstraZeneca Has Resumed Its U.K. COVID-19 Vaccine Trial | Time
